Latrepirdine and its Impurities

Latrepirdine has been investigated for the treatment of Alzheimer's Disease and Huntington's Disease. Reference standards of Latrepirdine API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.

Displaying 4 results for Latrepirdine Impurities
Drug Reference Standards & Impurity Synthesis in India
PA 12 1790000

Latrepirdine

Latrepirdine


  • Catalogue No.:PA 12 1790000

  • CAS :

    3613-73-8

  • Molecular Formula : C21H25N3

  • Molecular Weight : 319.45

Drug Reference Standards & Impurity Synthesis in India
PA 12 1791000

2,3,4,5-Tetrahydro-8-methyl-5-[2-(6-methylpyridin-3-yl)ethyl]-1H-pyrido[4,3-b]indole

2,3,4,5-Tetrahydro-8-methyl-5-[2-(6-methylpyridin-3-yl)ethyl]-1H-pyrido[4,3-b]indole


  • Catalogue No.:PA 12 1791000

  • CAS :

    23224-24-0

  • Molecular Formula : C20H23N3

  • Molecular Weight : 305.43

Drug Reference Standards & Impurity Synthesis in India
PA 12 1791001

5-(2-(2,8-Dimethyl-1,2,3,4-tetrahydro-5H-pyrido[4,3-b]indol-5-yl)ethyl)picolinic Acid

5-(2-(2,8-Dimethyl-1,2,3,4-tetrahydro-5H-pyrido[4,3-b]indol-5-yl)ethyl)picolinic Acid


  • Catalogue No.:PA 12 1791001

  • CAS :

    1147893-81-9

  • Molecular Formula : C21H23N3O2

  • Molecular Weight : 349.43

Drug Reference Standards & Impurity Synthesis in India
PA 12 1791002

2,8-Dimethyl-5-(2-(6-methylpyridin-3-yl)ethyl)-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indole 2-Oxide

2,8-Dimethyl-5-(2-(6-methylpyridin-3-yl)ethyl)-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indole 2-Oxide


  • Catalogue No.:PA 12 1791002

  • CAS :

    1147893-84-2

  • Molecular Formula : C21H25N3O

  • Molecular Weight : 335.45

pharmaffiliates